Health product recall

Simplexa Covid-19 Direct

Last updated

Summary

Product
Simplexa Covid-19 Direct
Issue
Medical devices - Performance issue
COVID
What to do

Discontinue using remaining inventory, share recall notice with users, complete/return response form.

Audience
Healthcare

Affected products

Affected products

Lot or serial number

Model or catalog number

Simplexa Covid-19 Direct

13967N
13968N
15061N
13330N
13331N
14016N
13336N

MOL4150

Issue

Customer complaints were received for disc leaks while running Simplexa Covid-19 Direct kit with assay definition version 2 (high spin & temp). Leakage was confirmed by retain testing on 1/6/22 with discs run on Covid-19 Direct assay definition version 2. No disc leakage occurred with version 3 (reduced spin & temp). Simplexa Flu A/B & RSV (mol2655) and Simplexa Covid-19 & Flu A/B Direct (mol4250) have similar assay definitions and are also at risk for leakage.

Recall start date: February 01, 2023

Additional information

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Microbiology
Companies

Diasorin Molecular LLC

11331 Valley View Street, Cypress, California, United States, 90630

Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-72669

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe